CL2012000725A1 - Immunogenic composition comprising at least 2 different saccharides separately conjugated with the same type of carrier protein. (divisional application n ° 1640-06) - Google Patents

Immunogenic composition comprising at least 2 different saccharides separately conjugated with the same type of carrier protein. (divisional application n ° 1640-06)

Info

Publication number
CL2012000725A1
CL2012000725A1 CL2012000725A CL2012000725A CL2012000725A1 CL 2012000725 A1 CL2012000725 A1 CL 2012000725A1 CL 2012000725 A CL2012000725 A CL 2012000725A CL 2012000725 A CL2012000725 A CL 2012000725A CL 2012000725 A1 CL2012000725 A1 CL 2012000725A1
Authority
CL
Chile
Prior art keywords
same type
immunogenic composition
carrier protein
divisional application
different saccharides
Prior art date
Application number
CL2012000725A
Other languages
Spanish (es)
Inventor
Dominique Boutriau
Carine Capiau
Jan Poolman
Ralph Leon Biemans
Philippe Denoel
Pierre Duvivier
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=69650458&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012000725(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0513071.1A external-priority patent/GB0513071D0/en
Priority claimed from GBGB0513069.5A external-priority patent/GB0513069D0/en
Priority claimed from GB0515556A external-priority patent/GB0515556D0/en
Priority claimed from GB0524204A external-priority patent/GB0524204D0/en
Priority claimed from GB0526041A external-priority patent/GB0526041D0/en
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of CL2012000725A1 publication Critical patent/CL2012000725A1/en

Links

Abstract

Composición inmunogénica que comprende al menos 2 sacáridos diferentes conjugados por separado con el mismo tipo de proteína vehículo (Divisional Sol. 1640-06).Immunogenic composition comprising at least 2 different saccharides conjugated separately with the same type of carrier protein (Divisional Sol. 1640-06).

CL2012000725A 2005-06-27 2012-03-23 Immunogenic composition comprising at least 2 different saccharides separately conjugated with the same type of carrier protein. (divisional application n ° 1640-06) CL2012000725A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0513071.1A GB0513071D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GB0515556A GB0515556D0 (en) 2005-07-28 2005-07-28 Immunogenic composition
GB0524204A GB0524204D0 (en) 2005-11-28 2005-11-28 Immunogenic composition
GB0526041A GB0526041D0 (en) 2005-12-21 2005-12-21 Immunogenic composition

Publications (1)

Publication Number Publication Date
CL2012000725A1 true CL2012000725A1 (en) 2012-08-31

Family

ID=69650458

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000725A CL2012000725A1 (en) 2005-06-27 2012-03-23 Immunogenic composition comprising at least 2 different saccharides separately conjugated with the same type of carrier protein. (divisional application n ° 1640-06)

Country Status (1)

Country Link
CL (1) CL2012000725A1 (en)

Similar Documents

Publication Publication Date Title
RS50660B (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
UY31177A1 (en) NAFTALENISOXAZOLINE AGENTS FOR THE CONTROL OF INVERTEBRATE PESTS
RS50510B (en) FORMULATIONS CONTAINING ECTEINASCIDINE AND DISAHARID
WO2006015357A3 (en) 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
ECSP034600A (en) LACTAMA COMPOUNDS
MA30153B1 (en) ANTI-OX40L ANTIBODIES AND CORRESPONDING METHODS
BRPI0620229A8 (en) formulation
EP1708719A4 (en) Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use
AR058753A1 (en) USE OF NUTRITIONAL COMPOSITIONS WITH SPHINGOLIPID PHOSPHOLIPIDS AND CHOLESTEROL
BR0213207A (en) peptide remodeling and glycoconjugation
BRPI0511008A (en) il-13 binding agents
BRPI0606687A2 (en) nutraceutical compositions
CY1109916T1 (en) Benzimidazolo-thiophene compounds as PLK inhibitors
GT200200069A (en) DERIVATIVES OF MERCAPTOACETILAMIDE, PROCEDURE FOR PREPARATION AND USE
BR0113964B1 (en) Adhesive composition Based on polychloroprene dispersions, self-contact adhesive thereof, as well as its process for preparation and application.
GT200800107A (en) ORAL FORMULATIONS THAT INCLUDE TIGECICLINE
ECSP078057A (en) FORMULATIONS OF CONJUGATED ESTROGENS AND BAZEDOXIFEN
CO6351708A2 (en) SUBSTRATES THAT HAVE FORMULATIONS WITH AN IMPROVED TRANSFER
ATE452646T1 (en) COMPOSITIONS WITH EPIGALLOCATECHINGALLATE AND PROTEIN HYDROLYZATE
ATE478125T1 (en) REVERSIBLE THERMOCHROMIC COMPOSITIONS
BRPI0414008B8 (en) compounds that bind to a thrombopoietin receptor, compositions and in vitro methods for activating a thrombopoietin receptor in a cell
MX2007010990A (en) Endoparasiticide.
BR0212353A (en) Compound, pharmaceutical composition, and use of a compound
DE602005009681D1 (en) HAIR TREATMENT COMPOSITIONS WITH A DISACCHARIDE; A DISEASE AND AN AMMONIUMION SOURCE
BRPI0408848A (en) oral cladribine formulations